Profile: FDA’s Bakul Patel On The Inevitable Future Of Digital Health

 
• By Ferdous Al-Faruque
  
Generate a summary of this article
Listen to this article
Beta

Medtech Insight profiles the man leading the US FDA’s digital health efforts to learn about his journey and vision for the future.

Behtany Hills and Bakul Patel
LIFE SCIENCE ATTORNEY BETHANY HILLS AND THE FDA'S BAKUL PATEL TALK ABOUT THE FUTURE OF DIGITAL HEALTH AT THE 2019 WORLD MEDICAL INNOVATION FORUM IN BOSTON • Source: Ferdous Al-Faruque

Over the past decade, digital health has become a burgeoning sector and ubiquitous term within the medical device industry. As a mountain of new digital heath products are headed to market, everyone is looking to Bakul Patel, associate director for digital health at the Center for Devices and Radiological Health (CDRH), to help develop a new least-burdensome pathway that also ensures patients are kept safe.

In 2017, Patel spoke to a group of stakeholders at the AdvaMed Digital Medtech Conference where he acknowledged that unlike...

Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

SpotifyApple PodcastsWebsite

More from Leadership

News We’re Watching: New OPEQ Head, Constructive Bio Funding Round, Natera Wins Injunction In Patent Suit

 
• By Natasha Barrow, Brian Bossetta, Elizabeth Orr, and Marion Webb

This week, the FDA announced a new head of its device evaluation office; synthetic genomics firm Constructive Bio landed $58m in funding; and Natera got a permanent injuction against NeoGenomics Labs' RaDaR assay.

J&J MedTech Keeps Up Cardiovascular Momentum With Shockwave E8 Launch In US

Tim Schmid, executive VP and worldwide chairman of J&J MedTech, expects Shockwave, acquired in April, and Abiomed, purchased in late 2022, to be “long-term gems” for the company. Cardiovascular is among higher-growth segments where J&J has concentrated investments in recent years, along with robotic surgical systems.

Pilot To Program: FDA Issues Accreditation Scheme For Conformity Assessment Draft Guidances

 
• By Brian Bossetta

The US FDA has published a trio of draft guidance documents for its Assessment Scheme for Conformity Program, which began as a pilot in September 2020 to capitalize on the role of standards in the regulation of medical devices.

Six Deaths linked To Inari Clot Removal Device

 
• By Brian Bossetta

Inari Medical is updating use instructions for a clot-removing catheter due to the potential for serious adverse effects, including death.

More from Medtech Insight

Test Focus Of Tariff Conversations Shifts To Stability, AdvaMed Says - Clone

 
• By Elizabeth Orr

AdvaMed president Scott Whitaker said the group is focused on the need for tariff stability in conversations with the Trump administration. The organization remains optimistic about other policy areas. New chairman and ResMed CEO Mick Farrell laid out his five priorities.

US Original PMAs and Panel-Track Supplementss

 
• By Olga Zviezdicheva, Reed Miller, and Nabil

Class III devices and panel-track supplements approved by US FDA’s Center for Devices and Radiological Health. Data derived from FDA.gov. Updated weekly.

Test Focus Of Tariff Conversations Shifts To Stability, AdvaMed Says

 
• By Elizabeth Orr

AdvaMed president Scott Whitaker said the group is focused on the need for tariff stability in conversations with the Trump administration. The organization remains optimistic about other policy areas. New chairman and ResMed CEO Mick Farrell laid out his five priorities.